Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Unum Therapeutics
3203
Unum Therapeutics
Technology
Biotechnology
Unum Therapeutics is a cellular therapeutics company ushering in a new wave in cancer immunotherapy.
Suggest edits
Founded
2014
Raised
$161.2M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Biogen
Xconomy
HubSpot
Formlabs
Money Mover
Akamai
General Catalyst
Companies in the same industry
Sequencing.com
Personal Genome Diagnostics
Aspect Biosystems
BioSig Technologies
GlaxoSmithKline
Gen9Bio
NuMedii
NextBio
Napatech
Visterra Inc.
Alexa global traffic share
Twitter followers
Overview
Funding
4
Add info
Add round
29 Mar
2018
$69,200,000
IPO
VC-backed Unum Therapeutics rolls out IPO
PE HUB
15 Mar
2017
$15,000,000
Debt financing
Square 1 Bank
Unum Therapeutics Receives $15M Credit Facility from Square 1 Bank
FinSMEs
11 Jun
2015
$65,000,000
Venture capital (Series B)
Atlas Venture
,
Wellington Management
,
New Leaf Venture Partners
,
+9
21 Oct
2014
$12,000,000
Venture capital (Series A)
Atlas Venture
,
Fidelity Biosciences
,
Sanofi-Genzyme BioVentures
